The Entheogenic Evolution

For this episode I speak with Joel Brierre and Corey Chase about how they got into working with 5-MeO and toad and their upcoming retreat in Jamaica

Tom Hatsis gave a response to the showing of the Psychedelica Episode of Mushrooms in Christian Art, and we followed it up with an interview regarding what he's uncovered in his research for his book, Psychedelic Mystery Traditions, which documents psychedelic use by Christians, but NOT mushrooms . . .

At the film festival that followed the conference, we showed the video of me taking 5-MeO-DMT and Jeff Tarrant doing an EEG scan. Here's the discussion and analysis that followed

We reach the end of postings from day two with the incomparable Rak Razam and "The Ocean in the Drop" - discussing the integration and transformation of the 5-MeO-DMT experience

Repeat offender, Merrill Ward, re-joins the Exploring Psychedelics stage with his talk on "Letting Go: Practical Techniques for Effective Ego Transcendence Through the Entheogenic Experience" on our section on 5-MeO-DMT

Filmmaker, event organizer for WBAC, and social activist Mario Garnier joins Exploring Psychedelics for the first time with his talk on "Developing the 5-MeO-DMT Community"

Dr. Octavio Rettig discusses both his practice of serving toad medicine and his research into Meso-American symbolism and mythology of toads, making the argument that 5-MeO-DMT consumption via toad was prevalent in the past but ultimately forgotten

Our section on 5-MeO-DMT starts out with survey results: "Qualitative Report of Advantages and Disadvantages of Consuming 5-MeO-DMT: Results from two Surveys"

SOU student Eric Grace shares his own story of "MDMA for Personal Healing"

Meriana Dinkova is welcomed back to the Exploring Psychedelics stage and the Entheogenic Evolution podcast with her return to the conference with her talk, "Empower Your Inner Shaman and Realize the Creator Within"

Psychologist Jeff Tarrant shares his work with EEG brain scans, psychedelics, neurofeedback, and spontaneous medicine reactivations with his first of two presentations at Exploring Psychedelics 2018

Gregory Wells and Veronika Gold bring ketamine into the mix for the first time at Exploring Psychedelics with their talk on "Starting a Ketamine-Assisted Psychotherapy Practice"

Phillip Perl makes his public speaking debut at Exploring Psychedelics 2018 with his talk, "A Qualitative Follow-up Study from MDMA-Assisted Psychotherapy for PTSD: Findings and Suggestions for Future Research"

Yashpal Jayne is back on the Exploring Psychedelics stage with his talk about using a variety of entheogenic medicines for personal transformation. Also in the episode is a call for support for an individual in Florida who is seeking a Religious Freedom exemption for his religious use of psilocybin mushrooms. He's seeking support for his legal fees here: https://www.gofundme.com/psychedelics-and-religious-freedom And you can read his supporting research here:...

Mike Crowley makes his triumphant return to Exploring Psychedelics with his talk on "Blue Mushrooms, Blue Gods," discussing the encoding of psychedelic mushrooms into Buddhist and Hindu mythology and iconography. To support the campaign to bring Ayahuasca spirituality to the Parliament of World religions, use this link: https://www.gofundme.com/ayahuasca-parliament-of-religions

Day two of Exploring Psychedelics kicks off by welcoming back Kevin Feeney for his talk, "Fly Agaric as Medicine: From Traditional to Modern Use"

Brad Adams explores themes of entheogenic experience and how they relate to Buddhist concepts of the self and the possibilities for self transformation

Are you ready for "Neuro-Psycho-Entheo Hacking: Psychonautic Engineering Healing Hacks for Optimal Living in the Post-Modern Era" with Justin Panneck? Sure you are!

Gwyllm Lwydd is welcomed back to the Exploring Psychedelics stage with this talk on "Fitz Hugh Ludlow and Hasheesh as a Psychedelic within the Transcendentalist Movement"

Preston Temple expands on the work of Thomas Ray discussing the future of psychedelic drug development via "designer drugs"